Testing a new catheter for better fluid collection during endoscopy
Evaluation of a Capillary Endoscopy Aspiration Catheter
This study is testing a new type of catheter to see if it can collect fluid from the small intestine more effectively during endoscopy for patients undergoing the procedure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT04418258 on ClinicalTrials.gov |
What this trial studies
This study evaluates a novel capillary endoscopy aspiration catheter designed to improve the efficiency of fluid collection from the small intestine during endoscopy procedures. The research compares the performance of this new catheter against the conventional aspiration catheter in terms of suction speed and volume of fluid collected. A total of 46 patients undergoing esophagogastroduodenoscopy at Cedars-Sinai Medical Center will participate, with each patient providing fluid samples using one of the two catheters. The goal is to determine if the capillary catheter can enhance the process of microbiota assessment in the small intestine.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-85 who are scheduled to undergo esophagogastroduodenoscopy.
Not a fit: Patients who are not undergoing endoscopy procedures will not benefit from this study.
Why it matters
Potential benefit: If successful, this new catheter could lead to more efficient and less contaminated fluid collection during endoscopic procedures, improving microbiome research and patient outcomes.
How similar studies have performed: While the conventional aspiration catheter is FDA-approved, the capillary catheter is a novel approach that has not been previously tested in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female subjects aged 18-85 undergoing esophagogastroduodenoscopy. Exclusion Criteria: * There are no exclusion criteria for this study as subjects will be undergoing the procedures for medical reasons and not for the purposes of this study.
Where this trial is running
Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Ali Rezaie, MD — Cedars-Sinai Medical Center
- Study coordinator: MAST Program
- Email: mastprogram@cshs.org
- Phone: (310) 423-0617
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.